由于GCH1基因变异模仿遗传性性帕巴雷西斯的Dopa响应性 dystonia,导致了遗传性性帕巴雷西斯
D Fontanesi1,2, Giulia Di Rauso3,4, F Cavallieri5
1Department of Biomedical, Metabolic and Neural Science, University of Modena and Reggio Emilia, Modena, Italy.
概括
对多巴反应性 dystonia (DRD) 可能被误诊为遗传性性帕拉帕雷西斯 (HSP). 早期识别微妙的 dystonia 症状和levodopa 治疗对于改善患者的治疗结果至关重要.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
背景情况:
- 多巴反应性 dystonia (DRD) 包括罕见的,基因决定的 dystonia 形式.
- 早期诊断和使用利沃多巴治疗显著改善患者的生活质量.
研究的目的:
- 为了强调在DRD中准确诊断的重要性.
- 强调DRD被误诊为遗传性性帕帕雷西斯 (HSP) 的可能性.
主要方法:
- 一个病人的病例报告,病人的步态逐渐减弱和硬.
- 临床评估包括运动唤起的潜力和基因检测 (GCH1变种).
- 最初的错误诊断为HSP,后来修订为DRD.
主要成果:
- 患者出现了最初暗示HSP的症状.
- 微妙的 dystonic 迹象和一种致病性 GCH1 变体导致了 DRD 诊断.
- 低剂量勒沃多巴治疗导致 significant 显著改善步态和 dystonia.
结论:
- 错误诊断DRD可能会推迟关键的治疗.
- 识别软性 dystonia 症状对于及时诊断至关重要.
- 对于疑似DRD病例,建议进行经验性Levodopa试验.
相关概念视频
Parkinson's Disease: Treatment
166
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
166
Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
Genetic Lingo
98.8K
Overview
98.8K
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K


